Bone repair cells for craniofacial regeneration.

Area of Science:

• Regenerative Medicine
• Craniofacial Surgery
• Cell-Based Therapies

Background:

• Complex craniofacial deformities present significant clinical challenges following injury, congenital defects, or disease.
• Cell-based therapies are emerging as advanced strategies to enhance regenerative responses in craniofacial wound healing.
• Research is ongoing to identify optimal scaffolds for delivering cell therapies in human regenerative medicine.

Purpose of the Study:

• To review the current applications of cell therapies for repairing bony and soft tissue defects within the oral and craniofacial complex.
• To highlight progress and insights into the development of cell therapies for clinical craniofacial regeneration.

Main Methods:

• Review of existing literature on cell-based therapies for craniofacial regeneration.
• Discussion of specific cell sources, such as bone marrow-derived stem and progenitor cells (e.g., ixmyelocel-T).
• Examination of manufacturing processes, including single-pass perfusion bioreactors for mesenchymal stem cells and progenitor cells.

Main Results:

• Ixmyelocel-T, containing CD90+ mesenchymal stem cells and CD14+ monocyte/macrophage progenitor cells, demonstrates potential for regenerating muscular, vascular, nervous, and osseous tissues.
• Somatic and stem cells are being utilized for treating complex osseous defects.

Conclusions:

• Cell therapies offer a promising avenue for craniofacial tissue regeneration, although the field is still in its early stages.
• Continued research and development are essential for translating these cell-based approaches into clinical practice for craniofacial reconstruction.